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Background:  The prevalence of type 2 diabetes in young adults and adolescents has increased in the last decade according to 
the increasing obese population. The aim of this study was to examine the clinical characteristics of patients diagnosed with dia-
betes mellitus before the age of 40 years as compared with patients diagnosed at older ages. 
Methods:  This was a cross-sectional, retrospective study using data from 350 diabetic patients who were diagnosed with diabe-
tes in an outpatient setting between January 2005 and December 2007. Patients were diagnosed according to the criteria set forth 
by the American Diabetes Association. We examined the clinical characteristics and laboratory data of the patients through re-
view of medical records and compared the early-onset diabetic patients (< 40 years old) and the usual-onset diabetic patients (≥ 
40 years old).
Results:  The frequency of early-onset diabetes and usual-onset diabetes were 31.1% (n=109) and 68.9% (n=241), respectively. 
The early-onset diabetic patients more often had a positive family history of diabetes; higher HbA1c, fasting glucose, and post-
prandial glucose levels; experienced typical symptoms more frequently; had microalbuminuria more frequently; and required 
insulin therapy as initial treatment more frequently as compared to usual-onset diabetic patients, and these differences were sig-
nificant. Conversely, hypertension was significantly more common in the usual-onset diabetic patients.
Conclusion:  It could be concluded that we should control early onset diabetes more strictly to prevent its complication because 
early onset diabetic patients represented more severe hyperglycemia and had more prevalent microalbuminuria. 
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INTRODUCTION 
Recently, the size of the aging population has increased with 
the increased life expectancy of the average individual, likely 
due to the westernization of many aspects of people’s lives, and, 
consequently, the prevalence of diabetes has skyrocketed around 
the world [1,2]. The prevalence of diabetes in Korea, which was 
estimated to be less than 1% in 1970, increased dramatically to 
7.6% of the total population in 2000 [3], and this trend is likely 
to continue. Additionally, the mortality rate of patients with 
diabetes was reported to be only 3 per 100,000 persons in 1979, 
whereas, in 2002, it was the fourth overall cause of death at 25 
per 100,000 persons, following cancer, cerebrovascular dis-
ease, and heart disease. Moreover, the fact that diabetes is the 
number one cause of loss of eyesight, foot amputation (not-
withstanding car accidents), and chronic renal failure requir-
ing dialysis, shows its seriousness [4].
  In the past, diabetes was primarily regarded as a chronic dis-
ease most commonly affecting the elderly population, but, re-
cently, the prevalence of early-onset (< 40 years of age) diabetes 
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has increased with the growing rate of obesity [5-7]. Consider-
ing that the duration of diabetes onset is directly associated 
with its complications, the occurrence of diabetes in younger 
individuals has serious ramifications for the health of the popu-
lation at large. However, it is well known that active blood sugar 
control through appropriate treatment can reduce the occur-
rence of the various diabetic complications, especially when the 
disease is detected early [8-10]. Additionally, the clinical charac-
teristics of early-onset diabetic patients and those of usual-onset 
(≥ 40 years of age) diabetic patients have been reported to be 
different [11-13]. Therefore, further elucidation of the unique 
clinical characteristics of young diabetic patients will provide 
vital information for a proper diabetes management for them. 
  However, there have been only a few researches on distribu-
tions of types and the clinical characteristics of early-onset di-
abetes, and studies comparing early-onset diabetes with usual-
onset diabetic patients are lacking in the literature. Therefore, 
the aim of the present study was to investigate the clinical char-
acteristics of diabetes patients diagnosed at less than 40 years 
of age and to compare their clinical manifestation with those 
of diabetes patients diagnosed at age of 40 or older. 
METHODS 
Subjects 
Study subjects were 350 diabetes patients newly diagnosed 
based according to criteria recommended by American Dia-
betes Association [14], selected among the patients who visit-
ed the outpatient clinic at endocrinology department of Bun-
dang CHA general hospital from January 2005 to December 
2007. Patients were divided into two groups based upon the 
age at diagnosis: the young group (< 40 years of age) and the 
older group (≥ 40 years of age). Patients who had previously 
used insulin preparations, oral hypoglycemic agents, or ste-
roids; those who had received anti-cancer chemotherapy for 
organ transplantation or a malignant tumor; and those who 
had undergone pancreatectomy were excluded from the study. 
Methods 
Data were collected by retrospective review of medical records 
and included the age of onset of diabetes, gender, height, max-
imal body weight before diabetes onset, body weight at diag-
nosis, family history of diabetes, typical symptoms of diabetes 
upon visiting the hospital (polyphagia, polyuria, and weight 
loss), systolic and diastolic blood pressures, and treatment re-
ceived during the first three months after diagnosis. A positive 
family history of diabetes was defined as having at least one 
1st-degree or 2nd-degree relative with diabetes. The presence 
of hypertension was defined as taking antihypertensive agents 
or a recorded systolic blood pressure ≥ 140 mmHg or diastolic 
blood pressure ≥ 90 mmHg. Body mass index (BMI) (kg/m
2) 
was calculated with patient’s weight (kg) divided by height 
squared (m
2). Maximal BMI was calculated using the maximal 
body weight before diagnosis. Upon diagnosis with diabetes 
mellitus, blood was drawn to determine the patient’s fasting 
blood glucose (glucose oxidase method), HbA1c (high perfor-
mance liquid chromatography, Bio-Rad Variant II; Bio-Rad 
Laboratories, Hercules, CA, USA), insulin (Roche Diagnostic 
GmbH, Mannheim, Germany), C-peptide (Roche Diagnostic 
GmbH), total cholesterol, triglycerides, and high density lipo-
protein cholesterol (HDL-C) and low density lipoprotein cho-
lesterol (LDL-C). Furthermore, 2-hour postprandial serum 
glucose, insulin, and C-peptide were also measured. Random 
urine microalbumin and creatinine were measured, and the 
albumin-to-creatinine ratio (ACR) was calculated. Microalbu-
minuria was assessed and defined as the presence of 30 mg of 
albumin/g of creatinine or 30 mg of albumin on 24-hour urine 
collection. The homeostasis model assessment of insulin resis-
tance (HOMA-IR) and homeostasis model assessment of β-cell 
function (HOMA-B) were calculated by using the formula of 
Matthews et al. [15]: HOMA-IR = fasting insulin (μU/mL) × 
fasting blood glucose (mmol/L) / 22.5 and HOMA-B = 20 × 
fasting insulin (μU/mL) / (fasting blood glucose [mmol/L] - 
3.5).
  Type 1 diabetes was diagnosed when the fasting C-peptide 
level was ≤ 0.6 ng/mL or autoantibodies were demonstrated, 
and type 2 diabetes was diagnosed when the fasting C-peptide 
level was ≥ 1.2 ng/mL. Cases that could not be classified were 
defined as “unclassified.” 
Statistical analysis 
Statistical analysis was conducted using the SPSS software pack-
age (version 11.5; SPSS Inc., Chicago, IL, USA), and statistical 
values were presented as mean ± standard deviation. Triglycer-
ides, insulin, C-peptide, HOMA-IR, and HOMA-B were shown 
with their medians (ranges). Because triglycerides, insulin, C-
peptide, HOMA-IR, and HOMA-B showed skewed distribu-
tions, they were analyzed after logarithmic transformation. 
Comparisons of the mean values of continuous variables be-
tween the two groups were analyzed by using the independent 121 Korean Diabetes J 2010;34:119-125 www.e-kdj.org
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sample t-test, and discontinuous variables using the chi-squared 
test. A P-value < 0.05 was considered to be statistically signifi-
cant. 
RESULTS 
Types of diabetes 
Fasting C-peptide levels of all subjects were measured. Of the 
20 patients who had their autoantibody levels measured, only 4 
were positive. The number of patients with type 1 diabetes, type 
2 diabetes, and unclassified diabetes were 8 (2.3%), 315 (90.0%), 
and 27 (7.7%), respectively. Of the 109 patients (31.1%) who 
were diagnosed at less than 40 years, 6.4% were type 1 diabetes, 
85.3% were type 2 diabetes, and 8.3% were unclassified diabe-
tes (Table 1).
Table 1. Type of diabetes mellitus according to age at diagnosis
Early onset
a
(n = 109)
Usual onset
b
(n = 241)
Total
(n = 350)
Type 1 DM 7 (6.4) 1 (0.4) 8 (2.3)
Type 2 DM 93 (85.3) 222 (92.1) 315 (90.0)
Unclassified 9 (8.3) 18 (7.5) 27 (7.7)
Data are expressed as number (%). 
DM, diabetes mellitus. 
a Early-onset, onset at < 40 years of age, 
b Usual-onset, onset at ≥ 40 
years of age.
Table 2. Clinical characteristics according to age at diagnosis
  Total Early onset
a Usual onset
b P value
No. 350 109 241
Age, yr 47.5 ± 13.5 31.8 ± 6.4 54.6 ± 9.3 <0.001
c
Male 232 (66.3%) 82 (75.2%) 150 (62.2%) 0.017
c
Family history 151 (43.1%) 67 (61.5%) 84 (34.9%) <0.001
c
BMI, kg/m
2 25.1 ± 3.6 25.5 ± 4.6 25.0 ± 3.1 0.261
Maximal BMI, kg/m
2 d 27.0 ± 3.7 27.8 ± 4.1 26.6 ± 3.4 0.017
c
Hypertension 148 (42.3%) 37 (33.9%) 111 (46.1%) 0.034
c
   Systolic BP, mm Hg
   Diastolic BP, mm Hg
130.1 ± 15.9
84.2 ± 11.9
126.5 ± 14.5
82.1 ± 13.0
131.6 ± 16.3
85.1 ± 11.3
0.006
c
0.033
c
Fasting glucose, mg/dL 200.7 ± 89.2 233.9 ± 118.0 185.3 ± 67.0 <0.001
c
PP 2 hour glucose, mg/dL 309.8 ± 114.7 337.3 ± 132.0 298.5 ± 105.1 0.012
c
HbA1c, % 9.7 ± 2.5 10.6 ± 2.7 9.2 ± 2.3 <0.001
c
Fasting C-peptide, ng/mL 2.38 (0.28 to 16.72) 2.15 (0.28 to 16.00) 2.47 (0.49 to 16.72) 0.287
PP 2 hour C-peptide, ng/mL 6.11 (0.28 to 21.40) 5.64 (0.28 to 21.40) 6.26 (0.85 to 19.92) 0.012
c
Fasting insulin, μU/mL 5.3 (1.0 to 117.4) 5.7 (1.0 to 117.4) 5.1 (1.0 to 30.1) 0.300
PP 2 hour insulin, μU/mL 22.0 (1.9 to 216.0) 21.5 (2.0 to 216.0) 23.4 (1.9 to 179.0) 0.683
HOMA-IR 2.30 (0.41 to 37.39) 2.63 (0.43 to 37.39) 2.25 (0.41 to 19.40) 0.046
c
HOMA-B 17.68 (1.53 to 640.36) 18.87 (1.53 to 640.36) 17.20 (1.90 to 98.05) 0.912
Total cholesterol, mg/dL 199.4 ± 41.4 202.9 ± 40.2 197.8 ± 41.9 0.291
Triglyceride, mg/dL 152 (42 to 1,194) 154 (46 to 1,194) 151 (42 to 783) 0.305
HDL-C, mg/dL 45.3 ± 11.2 44.6 ± 9.6 45.5 ± 11.9 0.498
LDL-C, mg/dL 117.0 ± 36.2 117.0 ± 32.1 117.1 ± 38.1 0.984
Microalbuminuria
e 58/241 (24.1%) 24/70 (34.3%) 34/171 (19.9%) 0.018
c
Data are expressed as mean ± standard deviation or number (%). 
BMI, body mass index; BP, blood pressure; HDL-C, high density lipoprotein cholesterol; HOMA-B, homeostasis model assessment of B-cell 
function; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low density lipoprotein cholesterol; PP, postprandial.
aEarly-onset, onset at < 40 years of age, 
bUsual-onset, onset at ≥ 40 years of age, 
cP < 0.05, early-onset vs usual-onset, 
dMaximal BMI, calculated 
using maximal weight, 
eMicroalbuminuria, albumin/creatinine ratio, ACR ≥ 30 or 30 mg/g of creatinine or mg/day and data are expressed as 
positive microalbuminuria number/measured microalbuminuria number (%).122
Kim K–S, et al.
Korean Diabetes J 2010;34:119-125 www.e-kdj.org
Clinical characteristics of subjects
Of the total 350 subjects, the mean age of diabetes onset was 
47.5 ± 13.5 years, and the mean BMI was 25.1 ± 3.6 kg/m
2. 
Among them, 232 patients (66.3%) were male and 151 patients 
(43.1%) had a positive family history of diabetes (Table 2). 
Differences in clinical characteristics according to age of 
onset 
The mean age of the young group and the older group was 31.8 
± 6.4 years was and 54.6 ± 9.3 years, respectively. The rate of 
males was higher in the young group compared with the older 
group, and the young group showed more frequent positive 
family history of diabetes, higher maximal BMI, higher fasting 
and postprandial glucose levels, higher HbA1c, and higher HO-
MA-IR compared with the older group. Although there were no 
differences in BMI, fasting C-peptide, fasting and postprandial 
insulin, HOMA-B, total cholesterol, triglycerides, HDL-C, or 
LDL-C between the two groups, the older group had a higher 
frequency of hypertension, higher systolic and diastolic blood 
pressures, and higher postprandial C-peptide levels. Although 
urinary albumin excretion was not measured in all subjects, 
among the 241 patients who were tested for urine albumin, mi-
croalbuminuria was found more frequently in the young group 
compared with older group (Table 2). 
Fig. 1. Distribution of early-onset and usual-onset diabetes ac-
cording to HbA1c level at diagnosist.
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Fig. 2. HbA1c levels according to age at diagnosis.
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Fig. 3. Frequencies of typical symptoms (A) and insulin treatment (B) according to age at diagnosis.
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  Among the young group, 20.2% had their HbA1c at diagno-
sis less than 8%, and 33% had those over 12%. In contrast, 36.9% 
of patients in the older group had their HbA1c at diagnosis less 
than 8% and 12.4% of patients had those over 12%. Therefore, 
the average blood glucose tended to be higher in the young 
group (P for trend < 0.05; Fig. 1). In addition, the younger the 
age of diabetes onset was, the higher HbA1c at diagnosis was 
shown (P for trend < 0.05; Fig. 2). 
Differences in symptoms and treatments according to age 
of onset
Typical symptoms of diabetes due to hyperglycemia (polyphagia, 
polyuria, and weight loss) were found in 63.3% of the young 
group, while they were found only in 29.9% of the older group 
(P < 0.05). During the first three months after diagnosis, 18.3% 
of the young group required insulin treatment compared to 
only 4.1% of patients in the older group (P < 0.05; Fig. 3). 
DISCUSSION 
As the prevalence and incidence of diabetes have skyrocketed 
around the world as well as in Korea due to lifestyle changes, 
concern about the disease is greater than ever. Moreover, diabe-
tes, a disease which was previously considered to be a chronic 
disease frequently found in the elderly, occurs in young adults 
and even in adolescents with gradual increase of prevalence. 
Due to a known close correlation between the development of 
complications and the disease duration, and due to the fact that 
the HbA1c level will increase gradually despite intensive treat-
ment, determining clinical characteristics of early-onset diabe-
tes patients and treating their disease properly are critical to 
prevent its complications. However, there have been only a few 
studies on the investigation of clinical characteristics of diabe-
tes occurring in young adults and adolescents, and comparing 
their characteristics with those in adults. 
  Researches performed in young diabetes patients have re-
ported the prevalence of type 1 and 2 diabetes differently. Ac-
cording to a report published in Korea [16], when 235 diabetes 
patients diagnosed at less than 35 years of age were classified 
according to their C-peptide levels, the rates of type 1, type 2, 
and unclassified diabetes were 13.8%, 80.3%, and 5.9%, respec-
tively. Another study [17] using data from 85 diabetes patients 
diagnosed at less than 30 years of age, reported that when the 
type of diabetes was classified according to the fasting C-pep-
tide level, the existence of autoantibodies, and the causes of ke-
toacidosis, the frequencies of type 1, type 2, and unclassified 
diabetes were 45.9%, 23.5%, and 25.9%, respectively. The pres-
ent study found that, among the 109 newly diagnosed patients 
at less than 40 years of age, the frequencies of type 1, type 2, and 
unclassified diabetes were 6.4%, 85.3%, and 8.3%, respectively. 
Possible reasons for this high rate of type 2 diabetes in this ear-
ly-onset diabetes population could be, i) because this study in-
vestigated only outpatients, some patients having type 1 diabe-
tes who initially presented with diabetic ketoacidosis could have 
been excluded, ii) because autoantibodies of all of the patients 
were not available, and iii) because the application of relatively 
higher age cutoff of early-onset diabetes could have led to high-
er prevalence of type 2 diabetes. The finding that most of the 
early-onset diabetes patients had type 2 diabetes, not type 1 di-
abetes, different from our expectation, may suggest that the in-
creasing rate of obesity is having a significant effect on the met-
abolic status of the younger population.
  Prevalence of diabetes diagnosed at young ages varies accord-
ing to researchers and regions. A study by Chuang et al. [12] 
conducted in Asians, reported that the prevalence of diabetes 
diagnosed at less than 30 years of age varied from 0.4 to 5.6% 
according to countries, and another study performed in Mexi-
cans showed that the prevalence of diabetes diagnosed at less 
than 40 years of age was 14% [18]. According to a study by Hilli-
er and Pedula [11], the prevalence of diabetes diagnosed at less 
than 45 years of age was 11.4%. The present study employed an 
age cutoff for early-onset diabetes as 40 years of age because this 
is the age at which diabetes screening was conducted in Korea, 
and four representative cohort studies on diabetes in Korea re-
ported that its prevalence increases significantly as patients reach 
the age of 40 and beyond [19]. The prevalence of diabetes diag-
nosed at less than 40 years of age observed in this study was 
31.1%, which was relatively higher than those reported in pre-
vious studies, and this discrepancy could be due to the fact that 
this study examined patients diagnosed with diabetes by their 
voluntary visit to the hospital, did not use questionnaires or 
employ the patients’ recollections, and excluded patients who 
had already taken oral hypoglycemic agents or insulin prepara-
tions. However, the findings of the present study were consis-
tent with those of previous studies that reported that changes 
in diet and reduced physical activity have led to a fast-growing 
obese population and an increase in the prevalence and inci-
dence of diabetes in younger persons [20-22]. 
  Among persons with a positive family history of diabetes, 
the disease is known to occur earlier, and obesity has been re-124
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ported to play a key role in its early onset. Shim et al. [23] re-
ported that diabetes occurred more earlier when persons had a 
family history of diabetes or a genetic predisposition to beta 
cell dysfunction along with associated insulin resistance, such 
as obesity. These results are concordant with those of the pres-
ent study, which showed that the young group had a higher rate 
of positive family history of diabetes, higher maximal BMI, and 
higher HOMA-IR than the older group. However, the finding 
that no difference in BMI according to age of onset was ob-
served, and that the maximal BMI was higher in the young 
group compared with the older group, suggests that efforts to 
reduce body weight and increase exercise to improve insulin 
sensitivity could decrease the occurrence of diabetes at younger 
ages because a rapid increase in body weight may lead to or ag-
gravate insulin resistance, and higher insulin resistance could 
be a factor provoking the development of diabetes. 
  In addition, the young group was observed to have higher 
fasting and postprandial blood glucose levels at diagnosis, high-
er HbA1c, more typical symptoms of the disease, and more 
prevalent microalbuminuria than the usual-onset group. Ch-
uang et al. [12] reported that, among type 2 diabetes patients 
diagnosed at less than 30 years of age, fasting blood glucose and 
HbA1c at diagnosis were higher than those of type 2 diabetic 
patients diagnosed at older ages. Park et al. [17] showed in their 
study performed in diabetes patients aged less than 30 years, 
that HbA1c levels at diagnosis and in 6.8-year follow-up, were 
higher than those of older patients with type 2 diabetes mea-
sured in other studies, and that the prevalence of complications 
was relatively higher in young diabetes patients with 32.9% of 
diabetic retinopathy, 22.4% of neuropathy and 16.4% of protei-
nuria. In line with the results with previous reports, the higher 
blood glucose levels in diabetes patients diagnosed at younger 
age compared with those in older group, could be considered 
because they had more possibility to visit a hospital due to di-
etary changes, decreased physical activity, increased work hours, 
and more confidence in their health. In addition, considering 
that young diabetes patients had lower postprandial C-peptide 
levels and higher HOMA-IR, their beta cell function might had 
been already declined with more serious degree of insulin re-
sistance, causing higher HbA1c levels. Therefore, complica-
tions of diabetes could progress faster and more seriously in 
young diabetes patients, and more efforts for early detection of 
the disease and for strict blood glucose control are warranted 
to deal with the future burden of complications in these young 
patients.
  This study has limitations as a cross-sectional and single 
center study. In addition, for microalbuminuria measured at 
diagnosis, there could be a possibility of false positive results 
caused by high blood sugar. However, our study is meaningful 
in that we compared various examination results and clinical 
characteristics at diagnosis according to the age of diabetes onset. 
Large-scaled, randomized, prospective studies are necessary to 
determine progressive clinical characteristics including the de-
velopment of complications and the outcomes of intensive 
blood sugar control in this patient population. 
  These days, the prevalence of young diabetes patients has in-
creased continuously. However, the rate of type 2 diabetes pa-
tients, different from our expectation, was high in this early-on-
set diabetes patients, and these young patients showed more 
frequent positive family history of diabetes, exhibited more typi-
cal symptoms associated with high blood sugar at diagnosis, 
and more prevalent microalbuminuria. Therefore, active and 
strict blood sugar control at its early stage is warranted to pre-
vent future diabetic complications. 
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